Announcements

MDPI will be attending the 2022 CAGPO ACMOO Annual Conference, hosted by the 2022 CAGPO Annual Conference Committee, which will be held from 15 to 18 September 2022 in Toronto, Canada.

The CAGPO mission statement is to unify general practitioners in oncology, promote communication amongst general practitioners in oncology in tertiary care and primary care settings, act and speak as the recognized authority on behalf of and for the benefit of general practitioners in oncology and their interests, and promote the role of general practitioners in oncology within cancer centers and within the primary care setting. The conference is to address the learning needs of general practitioners in oncology (GPOs) and oncology-allied health attendees. During this meeting, we will address recent advancements in the standards of oncology care. Our speakers include GPOs, medical and radiation oncologists, as well as speakers from the disciplines of family medicine and clinical trials.

The following MDPI journals will be represented:

• Current Oncology (leading);
• Cancers;
• Medical Sciences;
• Pharmacy;
• Journal of Clinical Medicine;
• Cells;
• Onco.

If you are attending this conference, please feel free to start an on-site conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have.

For more information about the conference, please visit the following link: http://cagpo-annual-conference.ca, or contact the Current Oncology Editorial Office at curroncol@mdpi.com.

MDPI will be attending the European Society of Cardiology (ESC) Congress 2022, hosted by the European Society of Cardiology and the European Heart House, which will be held from 26 to 29 August 2022 online and on-site in Barcelona, Spain.

The spotlight of the congress is “Global Cardiovascular Health”, focusing on an inclusive approach to cardiovascular health that takes into account the differences in the prevalence, clinical manifestations, prevention strategies, diagnostic modalities, and management of cardiovascular disease around the world. The ESC Congress 2022 is built on a solid foundation that attracts worldwide cardiology leaders to present and exchange their knowledge and most important research results. It focuses on the best and latest science but also emphasizes the importance of innovation, introducing topics at the frontiers of cardiovascular medicine and science to the attendees.

The following MDPI journals will be represented:

• Journal of Clinical Medicine (leading);
• Healthcare;
• Journal of Cardiovascular Development and Disease;
• International Journal of Environmental Research and Public Health;
• Cancers;
• Tomography;
• Data;
• Hearts;
• International Journal of Translational Medicine;
• Medicina;
• Medicines;
• Journal of Personalized Medicine.

The 2021 citation metrics have been released in the Journal Citation Reports (JCR), and we’re pleased to announce the following results for MDPI journals:

For more information on Impact Factors and what it means to index academic journals, please visit our related blog posts.

* Journals given their first Impact Factor in 2022

Source: 2021 Journal Impact Factors, Journal Citation Reports ^TM (Clarivate, 2022)

MDPI’s Young Investigator Awards recognize promising junior researchers, acknowledge their contributions, and enhance communication among scientists. We are proud to present the winners for the year 2021 in the “Medicine & Pharmacology” category. The winners were selected by the journals’ editors.

We warmly congratulate the awarded young investigators for their outstanding contributions. MDPI will continue to provide support and recognition to the academic community.

Biomedicines:

• Jasper Fuk-Woo Chan, Queen Mary Hospital, Hong Kong
• Mateusz Maciejczyk, Medical University of Bialystok, Poland

Current Oncology:

• Matteo Lambertini, University of Genova, Italy

Dentistry Journal:

• Helen Rogers, Newcastle University, UK

Healthcare:

• Amir Karami, University of South Carolina, USA

Journal of Clinical Medicine:

• Andrea Palermo, Campus Bio-Medico University, Italy

Journal of Personalized Medicine:

• Simone Di Franco, University of Palermo, Italy
• Catriona Hippman, University of Calgary, Canada

Medicina:

• Veeru Kasivisvanathan, University College London, UK
• Andrea Cortegiani, University of Palermo, Italy; University Hospital Policlinico Paolo Giaccone, Italy

Pharmaceutics:

• Qi Zhou, Purdue University, USA

We are proud to recognize the winners of MDPI’s 2021 Travel Awards in the “Medicine & Pharmacology” category for their outstanding presentations and to present them with the prize.

MDPI journals regularly offer travel awards to encourage talented junior scientists to present their latest research at academic conferences in specific fields, which helps to increase their influence.

The winners mentioned below were carefully selected by the journal editors based on an outline of their research and the work to be presented at an academic conference.

We would like to warmly congratulate the Travel Awards winners for the year 2021 and wish them the greatest success with their future research endeavors. MDPI will continue to enhance communication among scientists.

Biomedicines:

• Soheil Saeedi, University of Zurich, Switzerland

Dentistry Journal:

• Shawn Alexander Hallett, University of Michigan, USA

Medicines:

• Claire Albert, Yale University, USA

Pharmaceuticals:

• Raquel Filipa da Costa Viveiros, NOVA University of Lisbon, Portugal
• Patrick Jim Küppers, University Hospital Bonn, Germany

In order to acknowledge our reviewers, who so generously dedicate their time to reviewing papers, and demonstrate diligence, professionalism, and timeliness when reviewing manuscripts, MDPI journals regularly offer outstanding reviewer awards to scholars who participate in the peer-review process.

We are proud to recognize winners for the year 2021 in the “Medicine & Pharmacology” category for their outstanding contributions among extensive competition by presenting them with an Outstanding Reviewer Award.

We would like to take this opportunity to congratulate all of the winners on their achievement. MDPI will continue to provide support and recognition to the academic community.

Cancers:

• Antonio G. Solimando, University of Bari Aldo Moro, Italy
• Chenghui Li, University of Arkansas for Medical Sciences, USA
• Joaquim Carreras, Tokai University, Japan
• Pierfrancesco Franco, University of Turin School of Medicine, Italy
• Laurentiu Pop, University of Texas Southwestern Medical Center, USA

Current Oncology:

• Margaret Fitch, University of Toronto, Canada
• Caroline Mariano, BC Cancer Agency, Canada; University of British Columbia, Canada

Healthcare:

• Naser Alsharairi, Griffith University, Australia
• Peter W. Choate, Mount Royal University, Canada
• Qin Xiang Ng, National University of Singapore, Singapore

Journal of Clinical Medicine:

• Giulio Francesco, Sapienza University of Rome, Italy
• Sebastian Schnaubelt, Medical University of Vienna, Austria
• Olga Kislitsina, Northwestern University, Northwestern Memorial Hospital, USA

Journal of Personalized Medicine:

• Onofrio Laselva, University of Foggia, Italy
• Ping-Hsun Wu, Kaohsiung Medical University, Taiwan
• Vladimir Vladimirov, Virginia Commonwealth University, USA
• Mauro Giuffrè, University of Trieste, Italy

Medical Sciences:

• Erika Palmieri, National Cancer Institute at Frederick, USA

Tomography:

• Anjul Khadria, California Institute of Technology, Pasadena, USA

The purpose of our Best Paper Awards is to promote and recognize the most impactful contributions published within MDPI journals.

The editors of each journal carefully selected reviews and research papers through a rigorous judging process based on criteria such as the scientific merit, overall impact, and the quality of presentation of the papers published in the journal last year.

We are honored to present the winners in the “Medicine & Pharmacology” category, who were selected amongst extensive competition, and congratulate the authors for their outstanding scientific publications.

MDPI will continue to provide support and recognition to the academic community.

Antibiotics:

• “Antimicrobial and Synergistic Effects of Commercial Piperine and Piperlongumine in Combination with Conventional Antimicrobials”

by Eunice Ego Mgbeahuruike, Milla Stålnacke, Heikki Vuorela and Yvonne Holm

Antibiotics 2019, 8(2), 55; doi:10.3390/antibiotics8020055

• “Antibiotic Discovery: Where Have We Come from, Where Do We Go?”

by Bernardo Ribeiro da Cunha, Luís P. Fonseca and Cecília R. C. Calado

Antibiotics 2019, 8(2), 45; doi:10.3390/antibiotics8020045

Dentistry Journal:

• “Regeneration of the Periodontal Apparatus in Aggressive Periodontitis Patients”

by Zvi Artzi, Shiran Sudri, Ori Platner and Avital Kozlovsky

Dent. J. 2019, 7(1), 29; doi:10.3390/dj7010029

• “Treatment of Peri-Implant Mucositis with Repeated Application of Chlorhexidine Chips or Gel during Supportive Therapy—A Randomized Clinical Trial”

by Philipp Sahrmann, Cyrill Bettschart, Daniel B. Wiedemeier, Ahmed Al-Majid, Thomas Attin and Patrick R. Schmidlin

Dent. J. 2019, 7(4), 115; doi:10.3390/dj7040115

Healthcare:

• “Two-Year Use of Care Robot Zora in Dutch Nursing Homes: An Evaluation Study”

by Chantal Huisman and Helianthe Kort

Healthcare 2019, 7(1), 31; doi:10.3390/healthcare7010031

• “The Interlinked Rising Epidemic of Insufficient Sleep and Diabetes Mellitus”

by Vijay Kumar Chattu, Soosanna Kumary Chattu, Deepa Burman, David Warren Spence and Seithikurippu R. Pandi-Perumal

Healthcare 2019, 7(1), 37; doi:10.3390/healthcare7010037

Journal of Clinical Medicine:

• “Periodontitis: A Multifaceted Disease of Tooth-Supporting Tissues”

by Eija Könönen, Mervi Gursoy and Ulvi Kahraman Gursoy

Clin. Med. 2019, 8(8), 1135; doi:10.3390/jcm8081135

• “The Immunomodulatory Functions of Mesenchymal Stromal/Stem Cells Mediated via Paracrine Activity”

by Yueyuan Zhou, Yusuke Yamamoto, Zhongdang Xiao and Takahiro Ochiya

Clin. Med. 2019, 8(7), 1025; doi:10.3390/jcm8071025

• “Optimizing Detection of Kidney Transplant Injury by Assessment of Donor-Derived Cell-Free DNA via Massively Multiplex PCR”

by Tara K. Sigdel, Felipe Acosta Archila, Tudor Constantin, Sarah A. Prins, Juliane Liberto, Izabella Damm, Parhom Towfighi, Samantha Navarro, Eser Kirkizlar, Zachary P. Demko, Allison Ryan, Styrmir Sigurjonsson, Reuben D. Sarwal, Szu-Chuan Hseish, Chitranon Chan-On, Bernhard Zimmermann, Paul R. Billings, Solomon Moshkevich and Minnie M. Sarwal

Clin. Med. 2019, 8(1), 19; doi:10.3390/jcm8010019

Medicina:

• “Tumor Microenvironment”

by Borros Arneth

Medicina 2020, 56(1), 15; doi: 10.3390/medicina56010015

• “Comparative Epidemiology and Resistance Trends of Common Urinary Pathogens in a Tertiary-Care Hospital: A 10-Year Surveillance Study”

by Márió Gajdács, Marianna Ábrók, Andrea Lázár, and Katalin Burián

Medicina 2019, 55(7), 356; doi: 10.3390/medicina55070356

Pharmaceutics:

• “3D Printed Pellets (Miniprintlets): A Novel, Multi-Drug, Controlled Release Platform Technology”

by Atheer Awad, Fabrizio Fina, Sarah J. Trenfield, Pavanesh Patel, Alvaro Goyanes, Simon Gaisford and Abdul W. Basit.

Pharmaceutics 2019, 11(4), 148; doi:10.3390/pharmaceutics11040148

• “Mathematical Modeling of Release Kinetics from Supramolecular Drug Delivery Systems”

by Constantin Mircioiu, Victor Voicu, Valentina Anuta, Andra Tudose, Christian Celia, Donatella Paolino, Massimo Fresta, Roxana Sandulovici and Ion Mircioiu

Pharmaceutics 2019, 11(3), 140; doi:10.3390/pharmaceutics11030140

The 2021 citation metrics have been officially released in Scopus!

We are pleased to announce that 182 MDPI journals are included, of which:

● 21 journals received their first CiteScore.
● 85% of journals increased their CiteScore from 2020.
● 155 journals (85%) ranked above average, in at least one category.

The following 65 MDPI journals (36%) ranked among the top 25% of journals, in at least one category:

Source: 2021 CiteScores™ (Elsevier)

We are pleased to announce a new project of Journal of Clinical Medicine (JCM, ISSN: 2077-0383)—Special Issue Development Program.

The program aims to provide early career scientists with the opportunity to develop a Special Issue and experience the academic editor's role under the mentorship of an experienced scientist.

What you will receive from the Special Issue Development Program:

• A Guest Editor certificate;
• A platform to collect papers on a certain topic;
• Guidance from experienced scientists from JCM;
• More editorial experience and the opportunity to enrich your resume.

If you are interested in this opportunity, please send your Special Issue proposal to the JCM Editorial Office (jcm@mdpi.com) or submit the proposal at the following link: https://www.mdpi.com/journalproposal/sendproposalspecialissue/jcm. We will then discuss our potential collaboration and how the process works in detail.

In addition to the new Special Issue Development Program, JCM continues to welcome Special Issue proposals based on hot research topics.

1. Please briefly introduce yourself.

My name is Marco Sebastiani, professor of rheumatology at the University of Modena and Reggio Emilia. For many years, I’ve been working in some fields of rheumatology, such as rheumatoid arthritis, interstitial lung disease associated to rheumatic diseases, videocapillaroscopy in diagnosis and the management of connective tissue diseases, and cryoglobulinaemic vasculitis.

2. What attracted you to science editing?

Science-editing was a new work opportunity for me. It was a challenge to try to increase my expertise in other scientific fields.

3. The Journal of Clinical Medicine (JCM) is an open access journal. Can you explain your attitude toward open access? How do you think open access affects authors?

Open access is a good opportunity to increase the sharing and the diffusion of scientific progress. The authors can increase the visibility of their work. I frequently publish in open access journals, when I think that my work needs a large and rapid diffusion.

4. What are the current cutting-edge research areas in the field of immunology?

Immunology and rheumatology are experiencing a period of great research activity. The increase of knowledge in innate and acquired immunity, as well as in molecular mechanisms of inflammation, has allowed the discovery of new drugs and a better treatment of immune-mediated and inflammatory diseases. Moreover, in recent years, researchers have shown an increased interest in the lung’s involvement in rheumatic diseases; the development of new opportunities for treatment has induced research to search for new methods of screening and early diagnosis of interstitial lung disease.

5. What motivated you to join the JCM Editorial Board?

Journal of Clinical Medicine is a high-impact open access journal with an eminent Editorial Board. I accepted the opportunity to contribute to the journal and to collaborate with the other members of the Editorial Board with enthusiasm.

To work as a Section Editor-in-Chief of the Section “Immunology” is challenging, but rewarding, and it allows me to contribute to the development of the journal and keep up to date about all the activities of the journal.

6. How do you think COVID-19 affects medical research and publishing? Do you have any suggestions for the development of JCM during the epidemic period?